Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

Julia N. Faraonea Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA;c Molecular, Cellular, and Developmental Biology Program, The Ohio State University, Columbus, OH, USAView further author information

Panke Qua Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USAView further author information

Negin Goodarzia Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USAView further author information

Yi-Min Zhenga Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USAView further author information

Claire Carlind Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USAView further author information

Linda J. Saife Center for Food Animal Health, Animal Sciences Department, OARDC, College of Food, Agricultural and Environmental Sciences, The Ohio State University, Wooster, OH, USA;f Veterinary Preventive Medicine Department, College of Veterinary Medicine, The Ohio State University, Wooster, OH, USA;g Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USAView further author information

Eugene M. Oltzh Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USAView further author information

Kai Xua Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USAView further author information

Daniel Jonesi Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USAView further author information

Richard J. Guminad Department of Internal Medicine, Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA;j Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA;k Department of Physiology and Cell Biology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USAView further author information

Shan-Lu Liua Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA;b Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, USA;g Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA;h Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USACorrespondence[email protected]
View further author information

show all

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date